Drug Markets/Nimodipine

Nimodipine

4 NDCs across 2 manufacturers|4 Generic,0 Brand

Nimodipine is used to treat subarachnoid hemorrhage, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 28, 1988, and the first generic was approved Apr 17, 2007. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $797K on Nimodipine across 2,342 claims for 1,121 beneficiaries.

Nimodipine is available as 4 NDCs from 2 manufacturers (4 generic, 0 brand), with NADAC prices from $1.25 to $1.25 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

4G / 0B

Manufacturers

2

competing in market

Price Spread

$1.25 – $1.25

per EA

7d Activity

40 flat

avg +5.5% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

2 manufacturers producing NIMODIPINE

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Nimodipine used to treat?

Nimodipine is used to treat subarachnoid hemorrhage, per the National Library of Medicine's MED-RT classification.

When did Nimodipine become available as a generic?

FDA approved the first generic Nimodipine (ANDA) on Apr 17, 2007. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Nimodipine?

In 2024, Medicare Part D spent $797K on Nimodipine across 2,342 claims for 1,121 beneficiaries.

How many Nimodipine products are on the market?

The Nimodipine drug market contains 4 NDCs from 2 manufacturers — 4 generic and 0 brand products.

What is the price range for Nimodipine?

NADAC reference prices for Nimodipine range from $1.2542 to $1.2542 per EA.

Which manufacturers make Nimodipine?

2 manufacturers list Nimodipine in NADAC. Ranked by number of NDCs, the largest are Heritage Pharmaceuticals Inc. (2), Bionpharma Inc. (2).

How has the price of Nimodipine changed recently?

Over the past 7 days, 4 Nimodipine NDCs rose and 0 fell, with a market-wide average change of +5.5%.